Allogene Therapeutics Inc (ALLO)
2.40
-0.11
(-4.38%)
USD |
NASDAQ |
Sep 06, 16:00
2.40
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (% of Annual Revenues) Data
Date | Value |
---|---|
December 31, 2023 | -- |
December 31, 2022 | -- |
Date | Value |
---|---|
December 31, 2021 | -- |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.